How Profitable Is Coronavirus Vaccine Development?
In this Fool Live video, Healthcare and Cannabis Bureau Chief Corinne Cardina and longtime Motley Fool contributor Brian Orelli discuss whether there's money to be made from the coronavirus vaccines being developed by AstraZeneca (NYSE: AZN), Moderna (NASDAQ: MRNA), Pfizer (NYSE: PFE), BioNTech (NASDAQ: BNTX), and others. Investors know the initial sales prices of the vaccines because they've been pre-sold to government entities. The big question is whether there will be pressure to sell additional vaccine at close to cost. Fortunately, looking at the cost of flu vaccines, the current prices seem quite reasonable.
Source Fool.com
